CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV

Kathleen M. Kelly*, Carlo G. Tocchetti, Alexey Lyashkov, Patrick M. Tarwater, Djahida Bedja, David R. Graham, Sarah E. Beck, Kelly A. Metcalf Pate, Suzanne E. Queen, Robert J. Adams, Nazareno Paolocci, Joseph L. Mankowski

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)
5 Downloads (Pure)


Background - Diastolic dysfunction is a highly prevalent cardiac abnormality in asymptomatic as well as ART-treated human immunodeficiency virus (HIV) patients. Although the mechanisms underlying depressed cardiac function remain obscure, diastolic dysfunction in SIV-infected rhesus macaques is highly correlated with myocardial viral load. As cardiomyocytes are not productively infected, damage may be an indirect process attributable to a combination of pro-inflammatory mediators and viral proteins. Methods and Results - Given the diverse roles of CCR5 in mediating recruitment of leukocytes to inflammatory sites and serving as a receptor for HIV entry into cells, we investigated the role of CCR5 in the SIV/macaque model of diastolic dysfunction. We found that in SIV-infected macaques, CCR5 inhibition dramatically impacted myocardial viral load measured by qRT-PCR and prevented diastolic dysfunction measured by echocardiography. Complementary in vitro experiments using fluorescence microscopy showed that CCR5 ligands impaired contractile function of isolated cardiomyocytes, thus identifying CCR5 signaling as a novel mediator of impaired cardiac mechanical function. Conclusions - Together, these findings incriminate SIV/HIV gp120-CCR5 as well as chemokine-CCR5 interactions in HIV-associated cardiac dysfunction. These findings also have important implications for the treatment of HIV-infected individuals: in addition to antiviral properties and reduced chemokine-mediated recruitment and activation of inflammatory cells, CCR5 inhibition may provide a cardioprotective benefit by preventing cardiomyocyte CCR5 signaling.

Original languageEnglish
Article numbere000874
Pages (from-to)1-8
Number of pages8
JournalJournal of the American Heart Association
Issue number2
Publication statusPublished - 2 Apr 2014
Externally publishedYes

Bibliographical note

Copyright the Author(s) 2014. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.


Dive into the research topics of 'CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV'. Together they form a unique fingerprint.

Cite this